Last week, Bristol Myers BMY obtained FDA approval for a label expansion of its blockbuster immuno oncology drug Opdivo ...

The FDA's approval of Bristol Myers Squibb's Cobenfy for schizophrenia opens doors for Reviva's brilaroxazine, a ...

For instance, medications that help with the psychological effects of schizophrenia might also help with schizoid personality disorder. Stimulants, which are medications that energize people, and ...

The agency will offer earlier meetings with drugmakers as well as solicit more patient feedback on the process.

From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...

The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

New drug for schizophrenics has experts excited Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades. "This drug takes ...

People with schizophrenia will have a new treatment option ... Bristol Myers Squibb will sell the drug combination under the ...

While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...

Bristol-Myers Squibb's stock is set to rise with FDA approvals, acquisitions, and a strong oncology portfolio, despite ...

People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...